NYSE:WATLife Sciences
Waters (WAT) Is Up 5.2% After FDA Clears At-Home HPV Self-Collection Screening Kits
Waters Corporation recently reported that the FDA cleared the Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay for at-home cervical cancer screening, enabling prescription-based, insurance-covered kits that can be mailed to patients’ homes for sample collection and laboratory analysis.
This clearance marks a meaningful expansion of Waters’ presence in molecular diagnostics by pairing its post-BD acquisition capabilities with a comprehensive, at-home HPV testing...